Ginsenoside Rg3, one of the major ingredients of heat-processed ginseng, has been reported to inhibit the growth of various cancer cells. We previously reported that Rg3 inhibited the proliferation and induced apoptosis of breast cancer (MDA-MB-231) cells. In the present study, we have explored the mechanism underlying the anti-proliferative and proapoptotic effects of Rg3 in MDA-MB-231 cells, which have constitutively activated NF-κB and the mutant form of p53. Rg3 inhibited DNA binding and transcriptional activity of NF-κB and these effects were attributable to its suppression of IKKβ activity, degradation of IκBα and subsequent nuclear translocation of the p65 subunit of NF-κB. Similarly, the constitutive activation of ERK and Akt through phosphorylation was gradually reduced in MDA-MB-231 cells treated with Rg3. The pharmacological inhibitors of these kinases both U0126 (MEK1/2 inhibitor) and LY294002 (PI3K inhibitor) abrogated the NF-κB DNA binding activity in MDA-MB-231 cells. In addition, Rg3 treatment lowered the levels of the mutant p53 in concentration-and time-dependent manners. Rg3 also increased the association between p53 and its negative regulator Mdm2 in MDA-MB-231 cells. These findings suggest that Rg3 induced apoptosis in MDA-MB-231 cells, which is mediated by blocking NF-κB signaling via inactivation of ERK and Akt as well as destabilization of mutant p53. (J Cancer Prev 2014;19:23-30) 
INTRODUCTION
The roots of rhizome of Panax plants have been used for the treatment of many diseases and for enhancing physical strength and immunity. Among them, Panax ginseng C.A.
Meyer has a wide array of pharmacological and physiological effects.
1,2 Rg3, one of ginsenosides derived from heat-processed ginseng, was found to be a potent inhibitor of tumor cell growth. 3, 4 Rg3 induces apoptosis through generation of reactive oxygen species (ROS) in some cancer cells. 5, 6 In our previous study, Rg3 induced the proteolytic cleavage of caspase-3 and poly(ADP-ribose) polymerase (PARP) in human breast cancer MDA-MD231 cells. Moreover, a ROS scavenger attenuated the proteolytic cleavage of caspase-3 and down-regulation of Bcl-2 induced by Rg3. 6 In addition, it was reported that Rg3 inhibited the growth of colon and prostate cancer cells and enhanced their susceptibility to anti-cancer agents, which was associated with suppression of NF-κB activation. 7, 8 In many malignant tumors, constitutive NF-κB activation is observed, which is causally linked to inflammation, proliferation, resistant to apoptosis, invasion, etc. 9 Therefore, inhibition of abnormally elevated NF-κB activation in precancerous or malignant cells is considered to be an important strategy for cancer chemoprevention as well as therapy. 10 The mammalian NF-κB family includes p65/RelA, RelB, c-Rel, p50/p105 (NF-κB1), and p52/p100 (NF-κB2).
NF-κB proteins are characterized by the presence of a conserved 300-amino acid Rel homology domain located toward the N-terminus that is responsible for dimerization, interaction with IκBs, and binding to DNA. 11 These Rel family members can exist as homo-or heterodimers, the most abundant form of intracellular NF-κB is p50/p65
heterodimer. 12 Upon phosphorylation-mediated degradation of IκBα, active NF-κB is translocated into the nucleus, and regulates the expression of inducible genes encoding proteins involved in anti-apoptosis (e.g., IAPs, XIAP, and Bcl-2), cell proliferation (e.g., c-Myc, cyclooxygenase-2, and cyclin D1), and metastasis (e.g., MMP-9 and VEGF). 11, [13] [14] [15] Stabilization and overexpression of mutant p53 are hallmarks found in nearly 50% of human tumors. 16 There are also myriad of clinical studies correlating high levels of mutant p53 with more aggressive behavior of tumors and poor prognosis. Mutant p53 can inhibit the function of wild-type p53, possibly through oligomerization. 17 Ectopic expression of mutant p53 in p53-null cell lines can increase the oncogenic potential and drug resistance. 16, 18, 19 Thus, while the wild-type form of p53 is a tumor suppressor, mutant forms of p53 may function as oncoproteins. In this context, mutant p53 represents one of the most important clinical targets for anti-cancer drug intervention. 20 Wild-type p53 is destroyed when the proto-oncogene Mdm2 is overexpressed. Mdm2, by acting as an E3 ubiquitin ligase, down-regulates p53 through proteasome-mediated degradation. [21] [22] [23] In the present study, we have investigated effects of Rg3 on NF-κB and p53 signaling pathways in MDA-MB-231 cells.
MATERIALS AND METHODS
Materials
Rg3 was prepared and purified as described previously. 
Electrophoretic mobility shift assay (EMSA)
Confluent cells in 100 mm dishes were treated with Rg3.
Cells were gently washed twice with ice-cold PBS, scraped h. Finally, the gel was dried and exposed to an X-ray film.
Luciferase assay
A day before transfection, cells were subcultured at a density of 1×10 5 /ml in a 6-well plate to maintain 50% to an X-ray film. (Fig. 1A) . Rg3 also reduced the transcriptional activity of NF-κB as determined by the luciferase reporter gene assay in the same cells (Fig. 1B) . In addition, Rg3 treatment inhibited the nuclear translocation of the p65 subunit of NF-κB (Fig. 1C) . IKKβ is a protein kinase responsible for phosphorylation of IκBα which sequesters NF-κB in the cytoplasm. 12 Phosphorylated IκBα is rapidly polyubiquitinated and degraded by proteasomes, thereby liberating NF-κB for translocation into the nucleus and subsequent modulation of target gene expression. We also observed that Rg3 inhibited the degradation of IκBα (Fig. 1D ) and the catalytic activity of IKKβ (Fig.   1E ) as determined by Western blot analysis and the kinase assay, respectively.
Effects of Rg3 on activation of ERK and Akt
To further elucidate the molecular mechanism underlying suppression of NF-κB signaling by Rg3, we examined its effects on the activation of ERK and Akt, two major kinases 
Effect of Rg3 on the stability of mutant p53
In normal cells, p53 is present at very low levels due to rapid degradation mediated by Mdm2. Mdm2 binds to p53 and promotes its ubiquitination by acting as an ubiquitin E3
ligase. [21] [22] [23] p53 tumor suppressor gene is mutated in nearly 50% of human cancers. 16 In docetaxel. 7, 8 In our previous study, Rg3 pretreatment suppressed the NF-κB activation and expression of its major target protein cyclooxygenase-2 in mouse skin stimulated with the tumor promoter phorbol ester. prolongs TNF-α-induced NF-κB activation in cultured cells and intestinal organoid cultures. 42 Mice harboring a germline p53 mutation develop severe chronic inflammation and persistent tissue damage upon treatment with dextran sulfate sodium, and are highly prone to inflammation-associated colon cancer. 42 We observed that Rg3 proteins. 44 Targeted disruption of HDAC8 expression significantly triggers anti-proliferative effects in cells harboring with mutant p53, which is accompanied by decreased p53 expression. 44 In conclusion, Rg3 inhibited NF-κB signaling via possibly inactivation of ERK and Akt as well as destabilization of mutant p53, which may contribute to suppression of Bcl-2 expression and subsequently induction of apoptosis in MDA-MB-231 cells (Fig. 4) . 
